Niklas Engel is a Master's student in Molecular Biotechnology and Bioinformatics at Ruprecht-Karls University in Heidelberg. His research focus is on precision oncology and computational genomics, with the goal of improving cancer therapies for patients. He is currently contributing to this field as a research fellow at Harvard Medical School in Boston. Niklas is also interested in business and uses his expertise in the biotech and healthcare industry to help clients succeed in his role at Bain & Company. In his free time, Niklas enjoys ballroom dancing and playing the alto-saxophone.